IMMUNOASSAYS FOR PROSTATE SPECIFIC ANTIGEN

The present invention relates to the field of cancer immunoassay. Specifically, a new immunoassay method for prostate specific antigen (PSA) is presented. Also presented is a complex which resembles a complex of PSA and alpha -antichymotrypsin (ACT) that can be used as a calibrator or control in an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KING, CAROL, A, O'MORCHOE, SUSAN, B, DOWELL, BARRY, L, ALEXANDER, DEBRA, B, SMITH, ALLAN, H
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KING, CAROL, A
O'MORCHOE, SUSAN, B
DOWELL, BARRY, L
ALEXANDER, DEBRA, B
SMITH, ALLAN, H
description The present invention relates to the field of cancer immunoassay. Specifically, a new immunoassay method for prostate specific antigen (PSA) is presented. Also presented is a complex which resembles a complex of PSA and alpha -antichymotrypsin (ACT) that can be used as a calibrator or control in an immunoassay for PSA. Further presented is a method for fractionating polyclonal antibodies, to PSA, into those which bind epitopes that are masked by the binding of PSA to ACT and those which do not bind such epitopes. La présente invention concerne un immunodosage auquel on fait appel en cancérologie. De façon spécifique, un nouveau procédé d'immunodosage relatif à l'antigène spécifique de la prostate (PSA) est décrit. L'invention concerne également un complexe qui ressemble au complexe PSA et alpha -antichymotrypsine (ACT) qui peut être utilisé comme élément d'étalonnage ou témoin dans un immunodosage relatif au PSA. Est également décrit un procédé permettant de séparer, parmi des anticorps polyclonaux dirigés contre le PSA, ceux qui fixent des épitopes qui sont masqués par la liaison du PSA à l'ACT de ceux qui ne fixent pas de tels épitopes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO9518381A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO9518381A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO9518381A13</originalsourceid><addsrcrecordid>eNrjZNDy9PUN9fN3DA52jAxWcPMPUggI8g8OcQxxVQgOcHX2dPN0VnD0C_F0d_XjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx4f6WpoYWxhaGjobGRCgBAC8QJK8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMMUNOASSAYS FOR PROSTATE SPECIFIC ANTIGEN</title><source>esp@cenet</source><creator>KING, CAROL, A ; O'MORCHOE, SUSAN, B ; DOWELL, BARRY, L ; ALEXANDER, DEBRA, B ; SMITH, ALLAN, H</creator><creatorcontrib>KING, CAROL, A ; O'MORCHOE, SUSAN, B ; DOWELL, BARRY, L ; ALEXANDER, DEBRA, B ; SMITH, ALLAN, H</creatorcontrib><description>The present invention relates to the field of cancer immunoassay. Specifically, a new immunoassay method for prostate specific antigen (PSA) is presented. Also presented is a complex which resembles a complex of PSA and alpha -antichymotrypsin (ACT) that can be used as a calibrator or control in an immunoassay for PSA. Further presented is a method for fractionating polyclonal antibodies, to PSA, into those which bind epitopes that are masked by the binding of PSA to ACT and those which do not bind such epitopes. La présente invention concerne un immunodosage auquel on fait appel en cancérologie. De façon spécifique, un nouveau procédé d'immunodosage relatif à l'antigène spécifique de la prostate (PSA) est décrit. L'invention concerne également un complexe qui ressemble au complexe PSA et alpha -antichymotrypsine (ACT) qui peut être utilisé comme élément d'étalonnage ou témoin dans un immunodosage relatif au PSA. Est également décrit un procédé permettant de séparer, parmi des anticorps polyclonaux dirigés contre le PSA, ceux qui fixent des épitopes qui sont masqués par la liaison du PSA à l'ACT de ceux qui ne fixent pas de tels épitopes.</description><edition>6</edition><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; TESTING</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950706&amp;DB=EPODOC&amp;CC=WO&amp;NR=9518381A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950706&amp;DB=EPODOC&amp;CC=WO&amp;NR=9518381A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KING, CAROL, A</creatorcontrib><creatorcontrib>O'MORCHOE, SUSAN, B</creatorcontrib><creatorcontrib>DOWELL, BARRY, L</creatorcontrib><creatorcontrib>ALEXANDER, DEBRA, B</creatorcontrib><creatorcontrib>SMITH, ALLAN, H</creatorcontrib><title>IMMUNOASSAYS FOR PROSTATE SPECIFIC ANTIGEN</title><description>The present invention relates to the field of cancer immunoassay. Specifically, a new immunoassay method for prostate specific antigen (PSA) is presented. Also presented is a complex which resembles a complex of PSA and alpha -antichymotrypsin (ACT) that can be used as a calibrator or control in an immunoassay for PSA. Further presented is a method for fractionating polyclonal antibodies, to PSA, into those which bind epitopes that are masked by the binding of PSA to ACT and those which do not bind such epitopes. La présente invention concerne un immunodosage auquel on fait appel en cancérologie. De façon spécifique, un nouveau procédé d'immunodosage relatif à l'antigène spécifique de la prostate (PSA) est décrit. L'invention concerne également un complexe qui ressemble au complexe PSA et alpha -antichymotrypsine (ACT) qui peut être utilisé comme élément d'étalonnage ou témoin dans un immunodosage relatif au PSA. Est également décrit un procédé permettant de séparer, parmi des anticorps polyclonaux dirigés contre le PSA, ceux qui fixent des épitopes qui sont masqués par la liaison du PSA à l'ACT de ceux qui ne fixent pas de tels épitopes.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDy9PUN9fN3DA52jAxWcPMPUggI8g8OcQxxVQgOcHX2dPN0VnD0C_F0d_XjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXx4f6WpoYWxhaGjobGRCgBAC8QJK8</recordid><startdate>19950706</startdate><enddate>19950706</enddate><creator>KING, CAROL, A</creator><creator>O'MORCHOE, SUSAN, B</creator><creator>DOWELL, BARRY, L</creator><creator>ALEXANDER, DEBRA, B</creator><creator>SMITH, ALLAN, H</creator><scope>EVB</scope></search><sort><creationdate>19950706</creationdate><title>IMMUNOASSAYS FOR PROSTATE SPECIFIC ANTIGEN</title><author>KING, CAROL, A ; O'MORCHOE, SUSAN, B ; DOWELL, BARRY, L ; ALEXANDER, DEBRA, B ; SMITH, ALLAN, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO9518381A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>KING, CAROL, A</creatorcontrib><creatorcontrib>O'MORCHOE, SUSAN, B</creatorcontrib><creatorcontrib>DOWELL, BARRY, L</creatorcontrib><creatorcontrib>ALEXANDER, DEBRA, B</creatorcontrib><creatorcontrib>SMITH, ALLAN, H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KING, CAROL, A</au><au>O'MORCHOE, SUSAN, B</au><au>DOWELL, BARRY, L</au><au>ALEXANDER, DEBRA, B</au><au>SMITH, ALLAN, H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMMUNOASSAYS FOR PROSTATE SPECIFIC ANTIGEN</title><date>1995-07-06</date><risdate>1995</risdate><abstract>The present invention relates to the field of cancer immunoassay. Specifically, a new immunoassay method for prostate specific antigen (PSA) is presented. Also presented is a complex which resembles a complex of PSA and alpha -antichymotrypsin (ACT) that can be used as a calibrator or control in an immunoassay for PSA. Further presented is a method for fractionating polyclonal antibodies, to PSA, into those which bind epitopes that are masked by the binding of PSA to ACT and those which do not bind such epitopes. La présente invention concerne un immunodosage auquel on fait appel en cancérologie. De façon spécifique, un nouveau procédé d'immunodosage relatif à l'antigène spécifique de la prostate (PSA) est décrit. L'invention concerne également un complexe qui ressemble au complexe PSA et alpha -antichymotrypsine (ACT) qui peut être utilisé comme élément d'étalonnage ou témoin dans un immunodosage relatif au PSA. Est également décrit un procédé permettant de séparer, parmi des anticorps polyclonaux dirigés contre le PSA, ceux qui fixent des épitopes qui sont masqués par la liaison du PSA à l'ACT de ceux qui ne fixent pas de tels épitopes.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO9518381A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
title IMMUNOASSAYS FOR PROSTATE SPECIFIC ANTIGEN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T22%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KING,%20CAROL,%20A&rft.date=1995-07-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO9518381A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true